Tizolemide-induced changes of passive transport components across the basolateral membrane of isolated frog skin.
The effect on transepithelial Na transport of tizolemide was investigated in isolated frog skin (Rana temporaria). It was found that tizolemide (2-5 mM, serosal side) decreased transepithelial Na transport (measured as short circuit current and as net sodium flux) within 60 min to 25-40% of the control level resulting from reduction of the unidirectional sodium influx. Intracellular recording with microelectrodes revealed that these changes were associated with depolarization of the intracellular space to less than 40% of the control values (averaging - 71.7 +/- 5.1 mV) which is a consequence of a decrease in conductance of the basolateral border to about 25% of the control values. The conductance of the apical border was only slightly reduced. It is suggested that tizolemide blocks the partial conductance of potassium at the basolateral border which secondarily diminishes transepithelial Na transport due to a decrease of the driving force for apical border Na entry. A certain degree of inhibition of the Na-K-ATPase by tizolemide cannot be excluded. When vasopressin (ADH) was added to frog skin after treatment with tizolemide, the response was markedly reduced compared to that of untreated control preparations. Under these conditions, the conductance of the basolateral border increased while the apical border remained little influenced by the hormone--opposite to the response of frog skins under control conditions. It is concluded that the mode of action of ADH is more complex than has been recognized hitherto and includes effects at the basolateral border.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology*; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects*; D008839:Microelectrodes; D011896:Rana temporaria; D012867:Skin / Q000187:drug effects; D012964:Sodium / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology*; D053778:Thiazolidines; D014667:Vasopressins / Q000494:pharmacology*; D000096926:Benzenesulfonamides
D004232:Diuretics; D007473:Ion Channels; D012964:Sodium; D013449:Sulfonamides; D053778:Thiazolidines; D014667:Vasopressins; C023449:tizolemide; D000096926:Benzenesulfonamides